Not applicableUnknownNCT00390351What this trial is testingInvestigate the Diagnostic Value and Possibilities of OCT in Non-Melanoma Skin Cancer.Who this might be right forSkin Neoplasms Zealand University Hospital 120
Not applicableNot Yet RecruitingNCT07376512What this trial is testingPredicting Response to Anti-PD-1/PD-L1 Immunotherapy by Plasma Extracellular Vesicle AnalysisWho this might be right forNon-Small Cell Lung CancerMelanoma (Skin Cancer) Centre Georges Francois Leclerc 378
Not applicableUnknownNCT03621462What this trial is testingElucid Labs AIDA™ - Labelled Image Acquisition ProtocolWho this might be right forMelanoma (Skin)Basal Cell Carcinoma of the SkinSquamous Cell Carcinoma of the Skin Elucid Labs Inc. 4,000
Large-scale testing (Phase 3)Study completedNCT00324727What this trial is testingHepatic Arterial Infusion With Melphalan Compared With Standard Therapy in Treating Patients With Unresectable Liver Metastases Due to MelanomaWho this might be right forIntraocular MelanomaMelanoma (Skin)Metastatic Cancer Delcath Systems Inc. 93
Not applicableStudy completedNCT01477463What this trial is testingPilot Trial to Evaluate the Effect of Vitamin D on Melanocyte BiomarkersWho this might be right forMelanoma, Skin Stanford University 24
Not applicableWithdrawnNCT03518229What this trial is testingPilot Study of Intervention to Reduce Sunburns in Melanoma SurvivorsWho this might be right forMelanoma (Skin) University of Minnesota
Not applicableEnded earlyNCT05061940What this trial is testingThis SCR-103 Protocol Will Permit Sites to Proactively Assess TAA, HLA and HPV-16 Status in Patients With Selected Solid Tumors to Determine Suitability for Repertoire Immune Medicines Treatment Protocols.Who this might be right forHead and Neck CancerMelanomaHPV-Related Malignancy+5 more Repertoire Immune Medicines 22
Testing effectiveness (Phase 2)Study completedNCT00002786What this trial is testingBiological Therapy in Treating Patients With Metastatic MelanomaWho this might be right forMelanoma (Skin) Fred Hutchinson Cancer Center 20
Large-scale testing (Phase 3)Ended earlyNCT04410445What this trial is testingStudy to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for RecurrenceWho this might be right forMelanomaMelanoma Stage IIIMelanoma Stage IV+1 more Nektar Therapeutics 765
Early research (Phase 1)Active Not RecruitingNCT06377111What this trial is testingTest the Benefit of Vitamin B5 in Patients With MelanomaWho this might be right forMelanoma (Skin) University Health Network, Toronto 12
Testing effectiveness (Phase 2)Study completedNCT00012064What this trial is testingVaccine Therapy in Treating Patients With Stage IV or Recurrent MelanomaWho this might be right forMelanoma (Skin) Lisata Therapeutics, Inc. 56
Not applicableStudy completedNCT03518814What this trial is testingQuality of Life in Patients With Multimetastatic Melanoma Currently in Remission (QUALM)Who this might be right forMelanoma (Skin) Stage IVRemission Lille Catholic University 40
Not applicableEnded earlyNCT04734704What this trial is testingDefining the Role of the Skin Microbiome in Immune-related Adverse EventsWho this might be right forVitiligoSkin Melanoma University Hospital, Bordeaux 57
Early research (Phase 1)Study completedNCT00006368What this trial is testingYttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent CancerWho this might be right forBrain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more Novartis Pharmaceuticals 60
Testing effectiveness (Phase 2)Study completedNCT00003308What this trial is testingRadiation Therapy in Treating Patients With Newly Diagnosed Brain Metastases From Kidney Cancer, Melanoma, or SarcomaWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer+2 more Eastern Cooperative Oncology Group
Not applicableStudy completedNCT00416988What this trial is testingEducational Program in Skin Self-Examination To Detect Melanoma in Healthy ParticipantsWho this might be right forMelanoma (Skin)Weight Changes Rhode Island Hospital 1,135
Testing effectiveness (Phase 2)Ended earlyNCT02587650What this trial is testingCapmatinib, Ceritinib, Regorafenib, or Entrectinib in Treating Patients With BRAF/NRAS Wild-Type Stage III-IV MelanomaWho this might be right forALK Fusion Protein ExpressionBRAF wt AlleleInvasive Skin Melanoma+12 more University of California, San Francisco 1
Testing effectiveness (Phase 2)Study completedNCT00462982What this trial is testingSunitinib in Treating Patients With Brain Metastases Caused by Kidney Cancer or MelanomaWho this might be right forKidney CancerMelanoma (Skin)Metastatic Cancer Memorial Sloan Kettering Cancer Center 8
Not applicableLooking for participantsNCT06899789What this trial is testingLong-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitisWho this might be right forImmune Checkpoint Inhibitors-induced ColitisAdvanced Melanoma Skin Cancer, Non-small Cell Lung Carcinoma, Kidney AdenocarcinomaIleo-colitis+1 more Fondazione IRCCS Policlinico San Matteo di Pavia 250
Not applicableStudy completedNCT01482260What this trial is testingComparative Microarray Analysis in Primary Cutaneous Malignant MelanomaWho this might be right forCutaneous Malignant Melanoma Ruhr University of Bochum 21